NovaBridge Biosciences (NBP) Cash & Equivalents (2018 - 2025)
NovaBridge Biosciences (NBP) reported Cash & Equivalents of $210.6 million for Q4 2025, up 208.56% year-over-year from $68.3 million in Q4 2024, and down 7.64% on a QoQ basis from $228.1 million in Q3 2025.
NovaBridge Biosciences (NBP) has 8 years of Cash & Equivalents data on file, last reported at $210.6 million in Q4 2025.
- Quarterly Cash & Equivalents rose 208.56% year-over-year to $210.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $210.6 million (up 208.56% YoY) and the FY2025 annual result came in at $210.6 million, up 208.56% from the prior year.
- Cash & Equivalents slipped to $210.6 million in Q4 2025 per NBP's latest filing, from $228.1 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $737.0 million in Q2 2021 and bottomed at $53.6 million in Q1 2025.
- The 5-year median for Cash & Equivalents is $297.4 million (2023), against an average of $315.8 million.
- The widest annual swing landed in 2021, when Cash & Equivalents soared 233.79%; it then slumped 77.05% in 2024.
- Tracing NBP's Cash & Equivalents over 5 years: stood at $551.1 million in 2021, then slipped by 18.0% to $451.9 million in 2022, then sank by 34.18% to $297.4 million in 2023, then tumbled by 77.05% to $68.3 million in 2024, then soared by 208.56% to $210.6 million in 2025.
- Per Business Quant, the three latest NBP Cash & Equivalents figures stand at $210.6 million (Q4 2025), $228.1 million (Q3 2025), and $165.4 million (Q2 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 210.63 Mn |
| Sep 30, 2025 | 228.06 Mn |
| Jun 30, 2025 | 165.40 Mn |
| Mar 31, 2025 | 53.60 Mn |
| Dec 31, 2024 | 68.26 Mn |
| Sep 30, 2024 | 310.67 Mn |
| Jun 30, 2024 | 151.96 Mn |
| Dec 31, 2023 | 297.42 Mn |
| Jun 30, 2023 | 325.40 Mn |
| Dec 31, 2022 | 451.90 Mn |
| Jun 30, 2022 | 554.02 Mn |
| Dec 31, 2021 | 551.13 Mn |
| Jun 30, 2021 | 737.04 Mn |
| Dec 31, 2020 | 718.07 Mn |
| Sep 30, 2020 | 435.96 Mn |
| Jun 30, 2020 | 220.81 Mn |
| Dec 31, 2019 | 161.39 Mn |
| Sep 30, 2019 | 182.77 Mn |
| Dec 31, 2018 | 229.71 Mn |